Professional Documents
Culture Documents
The Global Burden of Antimicrobial
The Global Burden of Antimicrobial
The global nature of AMR calls for a global response, both in the geographic
sense and across the whole range of sectors involved. Nobody is exempt
from the problem.
Many calls to action on antimicrobial resistance have been made over the
past years. Countries with the strictest policies on antibiotic prescription now
report the lowest rates of bacterial resistance. However in most high income
countries, clinical use of antibiotics has not declined, despite frequent calls to
curtail overuse.
AMR has emerged as one of the principal public health problems of the 21st
century. This has resulted in a public health crisis of international concern,
which threatens the practice of modern medicine, animal health and food
security. The substantial problem of AMR is especially relevant to antibiotic
resistance (ABR), although antifungal resistance is increasing at an alarming
rate. Although the phenomenon of ABR can be attributed to many factors,
there is a well-established relationship between antibiotic prescribing
practices and the emergence of resistant bacteria.
Combating resistance has become a top priority for global policy makers and
public health authorities. New mechanisms of resistance continue to emerge
and spread globally, threatening our ability to treat common
infections. Antibacterial and antifungal use in animal and agricultural
industries aggravates selective pressure on microbes. A One Health approach
is urgently required.
Throughout the 1980s and 1990s, prolonged hospital and intensive care unit
stays were considered among the most important risk factors for harboring
ESBL Enterobacteriaceae along with exposure to broad-spectrum antibiotics.
However, most ESBL producing infections are now also in the community and
healthcare-associated settings as demonstrated in studies from Europe and
the Southeastern USA.
References